NEW YORK, March 1, 2016 /PRNewswire/ -- Award-winning New York-based agency Havas PR North America has been named public relations agency of record for ORIG3N, Inc., the Boston-based biotechnology company that is leading a transformation in the understanding and treatment of rare, genetically inherited diseases and is a pioneer in regenerative medicine.
Havas PR has embarked on a national public relations campaign that will help ORIG3N propel its patient-powered democratization of medical research. The agency's work will focus on PR for LifeCapsule and LifeProfiles; corporate visibility and thought leadership in the burgeoning field of regenerative medicine; strategic partnership development; as well as event marketing and brand visibility at high-profile events such as SXSW and the Boston Marathon.
"We're working to disrupt personalized medicine and are excited to have Havas PR as a strategic partner," said Robin Y. Smith, CEO of ORIG3N. "The team will help us secure greater visibility as we continue our momentum in reaching and motivating new audiences to take action and personally contribute to the future of medicine."
ORIG3N is a finalist in its SXSW Interactive Innovation Awards in the "Sci-fi No Longer" category, which is awarded for the coolest scientific achievement or discovery that before 2015 was only possible in science fiction.
"ORIG3N epitomizes the type of cutting-edge company that we find to be exhilarating clients," said Marian Salzman, CEO of Havas PR. "It is our great pleasure to help establish them as a pioneering force pushing the future of medicine."
Executive Vice President Julie Hall is the senior client lead with a New York-based account team with expertise in consumer healthcare, corporate visibility and brand marketing.
About Havas PR
Havas PR lives and thrives in New York City and three promising P's—Phoenix, Pittsburgh and Providence—proving through their successes that the "Local is the new global" trend (which we spotted many years ago) has truly come to life. We're newscrafters and buzz builders who launch and nurture brands that people admire, adore and emulate. For more information, go to us.havaspr.com.
About ORIG3N, Inc.
ORIG3N is leading a transformation in the understanding and treatment of rare, genetically inherited diseases. We've established the world's largest uniformly consented cell repository to better understand the cellular and molecular foundations of disease. The cells are ever-renewing and give rise to a living database of humanity we call LifeCapsule. Thousands of people have already contributed to advancing the future of healthcare—and to safeguarding their own future health. The founders are serial entrepreneurs whose previous venture, ArtusLabs, was acquired by PerkinElmer in 2011. For more information, visit www.orig3n.com.
Media Contact: Lisa Vanella, email@example.com, 917-602-7883
SOURCE Havas PR